339 related articles for article (PubMed ID: 29395286)
1. An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.
Rao S; Ghani M; Guo Z; Deming Y; Wang K; Sims R; Mao C; Yao Y; Cruchaga C; Stephan DA; Rogaeva E
Neurobiol Aging; 2018 Jun; 66():178.e1-178.e8. PubMed ID: 29395286
[TBL] [Abstract][Full Text] [Related]
2. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
[TBL] [Abstract][Full Text] [Related]
4. Analysis of whole genome sequenced cases and controls shows that the association of variants in
Curtis D;
J Neurogenet; 2021; 35(2):59-66. PubMed ID: 33970751
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region.
Jun G; Vardarajan BN; Buros J; Yu CE; Hawk MV; Dombroski BA; Crane PK; Larson EB; ; Mayeux R; Haines JL; Lunetta KL; Pericak-Vance MA; Schellenberg GD; Farrer LA
Arch Neurol; 2012 Oct; 69(10):1270-9. PubMed ID: 22869155
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
Nho K; Kim S; Horgusluoglu E; Risacher SL; Shen L; Kim D; Lee S; Foroud T; Shaw LM; Trojanowski JQ; Aisen PS; Petersen RC; Jack CR; Weiner MW; Green RC; Toga AW; Saykin AJ;
BMC Med Genomics; 2017 May; 10(Suppl 1):29. PubMed ID: 28589856
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
8. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
Jiang S; Yang W; Qiu Y; Chen HZ;
Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.
Wijsman EM; Pankratz ND; Choi Y; Rothstein JH; Faber KM; Cheng R; Lee JH; Bird TD; Bennett DA; Diaz-Arrastia R; Goate AM; Farlow M; Ghetti B; Sweet RA; Foroud TM; Mayeux R;
PLoS Genet; 2011 Feb; 7(2):e1001308. PubMed ID: 21379329
[TBL] [Abstract][Full Text] [Related]
11. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
[TBL] [Abstract][Full Text] [Related]
12. Association of APOE with tau-tangle pathology with and without β-amyloid.
Farfel JM; Yu L; De Jager PL; Schneider JA; Bennett DA
Neurobiol Aging; 2016 Jan; 37():19-25. PubMed ID: 26481403
[TBL] [Abstract][Full Text] [Related]
13. Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers.
Fan KH; Feingold E; Rosenthal SL; Demirci FY; Ganguli M; Lopez OL; Kamboh MI
J Alzheimers Dis; 2020; 76(4):1553-1565. PubMed ID: 32651314
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
15. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
Coon KD; Myers AJ; Craig DW; Webster JA; Pearson JV; Lince DH; Zismann VL; Beach TG; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Walker DG; Ravid R; Heward CB; Rogers J; Papassotiropoulos A; Reiman EM; Hardy J; Stephan DA
J Clin Psychiatry; 2007 Apr; 68(4):613-8. PubMed ID: 17474819
[TBL] [Abstract][Full Text] [Related]
16. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.
Medway CW; Abdul-Hay S; Mims T; Ma L; Bisceglio G; Zou F; Pankratz S; Sando SB; Aasly JO; Barcikowska M; Siuda J; Wszolek ZK; Ross OA; Carrasquillo M; Dickson DW; Graff-Radford N; Petersen RC; Ertekin-Taner N; Morgan K; Bu G; Younkin SG
Mol Neurodegener; 2014 Mar; 9():11. PubMed ID: 24607147
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
Kamboh MI
Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
[TBL] [Abstract][Full Text] [Related]
19. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
Bray NJ; Jehu L; Moskvina V; Buxbaum JD; Dracheva S; Haroutunian V; Williams J; Buckland PR; Owen MJ; O'Donovan MC
Hum Mol Genet; 2004 Nov; 13(22):2885-92. PubMed ID: 15385439
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.
Bertram L; Lange C; Mullin K; Parkinson M; Hsiao M; Hogan MF; Schjeide BM; Hooli B; Divito J; Ionita I; Jiang H; Laird N; Moscarillo T; Ohlsen KL; Elliott K; Wang X; Hu-Lince D; Ryder M; Murphy A; Wagner SL; Blacker D; Becker KD; Tanzi RE
Am J Hum Genet; 2008 Nov; 83(5):623-32. PubMed ID: 18976728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
